Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-7.48%
↑ 94% above average
Average (39q)
-127.15%
Historical baseline
Range
High:100.00%
Low:-4900.00%
Volatility
-3932.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -7.48% |
| Q2 2025 | -28.92% |
| Q1 2025 | 1.19% |
| Q4 2024 | -3.70% |
| Q3 2024 | -8.00% |
| Q2 2024 | -20.97% |
| Q1 2024 | 3.13% |
| Q4 2023 | 12.33% |
| Q3 2023 | -1.39% |
| Q2 2023 | -14.29% |
| Q1 2023 | -10.53% |
| Q4 2022 | 3.39% |
| Q3 2022 | -7.27% |
| Q2 2022 | -48.65% |
| Q1 2022 | 40.32% |
| Q4 2021 | -67.57% |
| Q3 2021 | 30.19% |
| Q2 2021 | -23.26% |
| Q1 2021 | -22.86% |
| Q4 2020 | -40.00% |
| Q3 2020 | -4900.00% |
| Q2 2020 | 97.83% |
| Q1 2020 | 0.00% |
| Q4 2019 | 100.00% |
| Q3 2019 | 12.82% |
| Q2 2019 | 11.36% |
| Q1 2019 | -29.41% |
| Q4 2018 | 52.11% |
| Q3 2018 | -29.09% |
| Q2 2018 | -150.00% |
| Q1 2018 | 51.11% |
| Q4 2017 | -4.65% |
| Q3 2017 | -4.88% |
| Q2 2017 | 2.38% |
| Q1 2017 | -27.27% |
| Q4 2016 | 35.29% |
| Q3 2016 | -21.43% |
| Q2 2016 | -82.61% |
| Q1 2016 | 14.81% |
| Q4 2015 | 0.00% |